Viewing Study NCT04324268


Ignite Creation Date: 2025-12-24 @ 5:45 PM
Ignite Modification Date: 2025-12-24 @ 5:45 PM
Study NCT ID: NCT04324268
Status: COMPLETED
Last Update Posted: 2023-04-18
First Post: 2020-03-24
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Evaluate Safety, Tolerability, and Bioavailability of Subcutaneous Lirentelimab (AK002) in Adult Healthy Volunteers
Sponsor: Allakos Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module